RecruitingNot Applicable

Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief

United States500 participantsStarted 2026-03-04

Plain-language summary

The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Participant who has been/is on multiple prescription medications to treat severe acid reflux on a regular basis or has had surgery for acid reflux.
✕. Participant with full or partial denture.
✕. Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease.
✕. Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis.
✕. Participants who have been informed by a DHCP that they have active caries.
✕. Participant with any chronic and/or severe painful health condition which lead to regular use of pain relief medications (more than 3 days a week).

What they're measuring

Change From Baseline in DHEQ Total Score at Week 24

Timeframe: Baseline and Week 24

Trial details

NCT IDNCT07300540

SponsorHALEON

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-11

Contact for this trial

Haleon Response Center

+441932959500 ww.clinical-trial-register@haleon.com

View on ClinicalTrials.gov More Dentin Sensitivity trials